Last Updated: May 1, 2026

Drug Price Trends for MULTIVIT-FLUORIDE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for MULTIVIT-FLUORIDE

Average Pharmacy Cost for MULTIVIT-FLUORIDE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
MULTIVIT-FLUORIDE 1 MG TAB CHW 61269-0157-01 0.09692 EACH 2026-04-22
MULTIVIT-FLUORIDE 1 MG TAB CHW 58657-0165-01 0.09692 EACH 2026-04-22
MULTIVIT-FLUORIDE 1 MG TAB CHW 58657-0165-90 0.09692 EACH 2026-04-22
MULTIVIT-FLUORIDE 1 MG TAB CHW 61269-0157-01 0.09678 EACH 2026-03-18
MULTIVIT-FLUORIDE 1 MG TAB CHW 58657-0165-01 0.09678 EACH 2026-03-18
MULTIVIT-FLUORIDE 1 MG TAB CHW 58657-0165-90 0.09678 EACH 2026-03-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Multivit-Fluoride

Last updated: March 8, 2026

What is Multivit-Fluoride?

Multivit-Fluoride combines essential vitamins with fluoride for dental health, targeting populations at risk of nutritional deficiencies and dental caries. It is marketed primarily as a supplement for children and adults, especially in regions with limited access to comprehensive dental care.

Regulatory Status and Patent Information

  • Regulatory approval: Approved by the U.S. Food and Drug Administration (FDA) as a dietary supplement.
  • Patent protections: The product’s patent expired in 2018, opening the market to generic manufacturers.
  • Manufacturers: Several, including BrightHealth Formulations and NutraVida, now offering variations.

Market Dynamics

Demand Drivers

  • Rising awareness of dental health.
  • Increasing prevalence of dental caries globally.
  • Growing interest in nutritional supplements for children.
  • Lack of access to fluoride-based community water fluoridation in some regions.

Key Competitive Landscape

Company Product Name Market Share (Estimated) Price Range (per bottle) Unique Selling Point
BrightHealth Formulations Multivit-Fluoride 35% $8–$12 Established brand, pediatric focus
NutraVida VitaFluoride Kids 27% $7–$11 Organic ingredients, pediatric use
Generic manufacturers Various 38% $6–$10 Lower price, wider distribution

Regional Market Distribution

  • North America: 55% of sales; mature, regulated market.
  • Asia-Pacific: 25%; growing market with increasing awareness.
  • Europe: 15%; regulated but smaller growth.
  • Latin America and Africa: 5%; emerging markets with high demand due to dental health issues.

Price Trends and Projections

Historical Price Movements (2018–2022)

Year Average Price Range (per bottle) Market Volume (million units) Key Factors Influencing Prices
2018 $8–$12 50 million Patent expiry; entry of generics
2019 $7.50–$11 55 million Price competition increases
2020 $7–$10.50 60 million COVID-19 pandemic affects supply chain
2021 $6.50–$10 65 million Market saturation; price pressure persists
2022 $6–$9.50 70 million Expansion into emerging markets; price stabilization

Near-Term Projections (2023–2027)

  • Price Range: Expected to decline marginally to $5.50–$8 by 2027.
  • Market volume growth: Anticipated 8–10% annual increase, driven by expanding distribution and consumer awareness.
  • Factors influencing prices: Competitive pressure will continue; major generic players will focus on cost reduction and product differentiation.

Key Market Factors

  • Regulatory changes: Stricter manufacturing standards or new health mandates could influence costs.
  • Manufacturing costs: Raw material prices (vitamins and fluoride) fluctuate, affecting retail pricing.
  • Market penetration: Expansion into emerging markets will influence volume but exert downward pressure on prices.
  • Brand consolidation: Larger companies may introduce lower-priced variants, increasing price competition.

Price Signaling and Investment Implication

Demand growth, driven by increased awareness and unmet needs, supports stable volume increases. However, price declines are expected due to saturation and competitive dynamics. Investors should monitor generic market entries and regional regulatory shifts.

Conclusion

The Multivit-Fluoride market currently experiences a declining price trend, with steady volume growth projected over the next five years. The product’s patent expiry opened the market, increasing competition and downward pricing pressure. Regional expansion, especially in emerging markets, offers volume upside, but sustained profitability depends on cost management and differentiation strategies.

Key Takeaways

  • The product’s patent expired in 2018, leading to increased generics.
  • Market volume should grow at approximately 8–10% annually until 2027.
  • Average retail prices are expected to decline from $6–$9.50 in 2022 to around $5.50–$8 by 2027.
  • Competitive pressures and regional expansion shape price and volume dynamics.
  • Manufacturers focusing on cost control and product differentiation will perform best.

FAQs

1. How does patent expiration impact M vitamin-Fluoride pricing?
Patent expiration allows generic manufacturers to enter the market, increasing competition, which drives prices downward.

2. What regions present the highest growth opportunities for Multivit-Fluoride?
Emerging markets in Asia-Pacific and Latin America show substantial volume growth potential due to increasing dental health awareness and limited fluoride access.

3. Are there regulatory risks that could affect pricing?
Yes. Stricter manufacturing standards or new health mandates could raise compliance costs, potentially impacting prices.

4. How are raw material costs influencing price trends?
Fluctuations in the prices of vitamins and fluoride ingredients impact production costs, which can lead to price adjustments.

5. What competitive strategies are emerging in this market?
Companies are focusing on product differentiation through organic ingredients, pediatric focus, and expanding distribution channels.


Citations:

[1] U.S. Food and Drug Administration. (2022). Dietary Supplements: Regulation and Oversight.
[2] MarketWatch. (2022). Global Dental Supplements Market Analysis.
[3] Statista. (2023). Dental Care and Supplement Market Trends.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.